TNBS administration induces transmural colitis that is driven by a TH1-mediated immune response, which is characterized by the infiltration of CD4+ cells, neutrophils, and macrophages into the lamina propria and the secretion of cytokines [29,30]. Here, CD4 is linked to colitis.